Scancell adds six worldleading cancer specialists to advisory board ahead of Modi1 trial

Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial

“The initial focus of the board will be to inform the clinical strategy for the planned Modi-1 clinical trial and to ensure the best possible outcome in several solid tumour indications”

More From BioPortfolio on "Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial"